Developing high-value bio-based health products and export-ready nutraceuticals at national scale

Program Objective and Strategic Role

The National Bioactive and Nutraceutical Innovation Program aims to establish a national development and industrialization framework that leverages domestic biological, botanical, and agricultural resources to support the research, development, and market deployment of high value-added bioactive and nutraceutical products.

The program is not pharmaceutical drug development, but focuses on:

• – dietary supplements and functional bioactive products,
• – prevention- and quality-of-life–oriented health solutions,
• – strengthening collaboration between research institutions, industry, and the public sector.

Core Program Logic

The program integrates three domains into a unified system:

1. Natural and Agricultural Foundations

• – domestic plant-based, microbial, and bio-derived resources,
• – sustainable cultivation and processing models,
• – traceable and transparent raw-material supply chains.

2. Scientific and Technological Development

• – bioactive compound research,
• – AI- and bioinformatics-supported formulation design,
• – quality assurance and validation methodologies.

3. Industrialization and Market Deployment

• – pilot manufacturing and scalable production,
• – regulation-compliant product positioning,
• – support for domestic and international market entry.

Key Development Pillars

1. National Bioactive Research and Formulation Platform

• – centralized bioactive compound databases,
• – analysis of synergistic interactions and mechanisms of action,
• – reproducible and standardized development workflows.

2. Nutraceutical Pilot and Scaling Program

• – development of pilot product lines,
• – involvement of small and medium-sized manufacturers,
• – quality-assured production models.

3. Regulatory and Market Support Framework

• – EU-compliant regulatory alignment,
• – support for documentation and approval processes,
• – export and brand development initiatives.

Program Phases (2–6 Years)

Phase 1 – Foundation and Pilot Phase (Years 1–2)

• – mapping of national bioactive resources,
• – launch of pilot nutraceutical development projects,
• – formation of research–industry consortia.

Phase 2 – Industrialization and Expansion (Years 3–4)

• – expansion of manufacturing capacities,
• – diversification of product portfolios,
• – entry into regional and EU markets.

Phase 3 – Consolidation and International Positioning (Years 5–6)

• – development of export-ready brands,
• – establishment of long-term industrial partnerships,
• – strengthening international presence in the health industry.

Institutional and Industry Stakeholders

• – agricultural and food-industry actors,
• – nutraceutical and functional food manufacturers,
• – universities and research institutes,
• – innovation and development agencies,
• – export and foreign-trade organizations.

Expected Economic and Societal Impact

• – creation of a high value-added national health-industry segment,
• – job creation and SME development,
• – growth in export revenues,
• – increased consumer health awareness,
• – sustainable bio-based economic models.

Alignment with the AVA Development Framework

Within this program, AVA functions as a development-support intelligence layer, enabling:

• – dentification of bioactive patterns and synergistic combinations,
• – support for formulation and portfolio decisions,
• – prioritization of market and development pathways.

The National Bioactive and Nutraceutical Innovation Program thus represents a commercially tangible yet scientifically grounded pillar of the national Bio–Nano and health-technology strategy.